ACROBiosystems Establishes French Presence at The HIVE Innovation Center
Biotechnology firm ACROBiosystems has opened a new specialized hub within The HIVE innovation center in Villejuif. The move aims to integrate into France's life science ecosystem and foster cancer research.
Biotechnology company ACROBiosystems has expanded its presence in France by opening a new specialized hub within The HIVE innovation center in Villejuif. The center, managed by Kadans Science Partner, is part of the Campus Grand Parc and focuses on life sciences.
ACROBiosystems' move to The HIVE is a strategic initiative to deepen its connections with the French life science community. The campus brings together biotechnology firms, hospitals, and research institutions, creating an environment where ACROBiosystems can leverage its global expertise to collaborate with those developing next-generation cancer therapies.
The new hub supports ACROBiosystems' mission to be a key partner in the rapid advancements within the biopharmaceutical and healthcare sectors. The company, employing nearly 1,000 people globally and serving thousands of clients, specializes in various stages of drug development, from proteins and antibodies to clinical applications.
Mike Chen, founder and CEO of ACROBiosystems, highlighted France, particularly the Paris-Saclay region, as a crucial intersection for world-class research and a burgeoning biotechnology ecosystem. "We are not just opening an office; we are becoming part of this ecosystem, listening, collaborating, and evolving alongside the teams working on tomorrow's treatments," Chen stated.
Sandrine Lo from Kadans Science Partner welcomed ACROBiosystems, viewing their choice as a strong indicator of Campus Grand Parc's growing international appeal.